A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome

Bladder cancer is a biologically heterogeneous disease with variable clinical presentations, outcomes and responses to therapy. Thus, the clinical utility of single biomarkers for the detection and prediction of biological behavior of bladder cancer is limited. We have previously identified and vali...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Runpu, Pagano, Ian, Sun, Yijun, Murakami, Kaoru, Goodison, Steve, Vairavan, Ramanathan, Tahsin, Malak, Black, Peter C., Rosser, Charles J., Furuya, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332739/
https://www.ncbi.nlm.nih.gov/pubmed/35892512
http://dx.doi.org/10.3390/diagnostics12081801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332739/
https://www.ncbi.nlm.nih.gov/pubmed/35892512
http://dx.doi.org/10.3390/diagnostics12081801

Ejemplares similares